# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Evercore ISI Group analyst Elizabeth Anderson upgrades Augmedix (NASDAQ:AUGX) from In-Line to Outperform and raises the pric...
Augmedix (NASDAQ:AUGX), a leader in ambient AI medical documentation and data solutions, today announced its go-to-market partn...
B. Riley Securities analyst Neil Chatterji reinstates Augmedix (NASDAQ:AUGX) with a Buy and announces $5.5 price target.
Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected four...
Evercore ISI Group analyst Elizabeth Anderson maintains Augmedix (NASDAQ:AUGX) with a In-Line and lowers the price target fr...
Maxim Group analyst Allen Klee maintains Augmedix (NASDAQ:AUGX) with a Buy and lowers the price target from $6.5 to $5.